Report center

血液透析行业深度报告：血液透析持续高景气度，看好全产业链布局企业-国元证券

液透析（HD）是世界上最常见的肾脏替代疗法，约占所有肾脏替代疗法的 69%和所有透析的89%，2022 年全球血液透析市场规模达到944.3亿美元，保持平稳增长。中国血液透析市场规模在 2022 年突破687 亿元，但透析治疗渗透率较低，2020 年中国接受透析治疗的ESRD 患者数量为 5.71 每万人口，远低于日本 26.82 每万人口和韩国23.76每万人口等发达国家。以2020年中国ESR

No subject companies

Publishers

国元证券 View content →

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

1国元证券Published by or linked to this institution1
2Healthcare ServicesSame industry · 1 related reports1

Ask about this report neighborhood Read full report →

Other hot industries

Healthcare Services View content →

No related reports

← Back to knowledge graph